Clinical Trials Browser

Unknown × Tyrosine Kinase Inhibitors × Gastrointestinal × Clear all

NCT06059885 2023-09-29

Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms

NCT02794337 2022-04-27

TACE-SBRT

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular